He Shou Wu Herb Use for Hair Growth Reviews
Pharmacognosy Res. 2015 Jul-Sep; 7(3): 225–236.
Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds
Guy-Armel Bounda
one Department of Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, China
YU Feng
i Department of Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, China
2 Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Ministry of Instruction, China
Received 2015 February ix; Revised 2015 Feb 18; Accepted 2015 Jun ii.
Abstract
Polygonum multiflorum Thunb. (PMT), officially listed in the Chinese Pharmacopoeia, is i of the well-nigh pop perennial Chinese traditional medicines known equally He shou wu in Mainland china and East Asia, and every bit Fo-ti in Due north America. Mounting pharmacological studies have stressed out its primal benefice for the treatment of various diseases and medical conditions such as liver injury, cancer, diabetes, alopecia, atherosclerosis, and neurodegenerative diseases also. International databases such equally PubMed/Medline, Science citation Index and Google Scholar were searched for clinical studies recently published on P. multiflorum. Various clinical studies published manufactures were retrieved, providing information relevant to pharmacokinetics-pharmacodynamics analysis, sleep disorders, dyslipidemia treatment, and neurodegenerative diseases. This review is an effort to update the clinical picture of investigations ever carried on PMT and/or its isolated bio-compounds and to enlighten its therapeutic assessment.
Keywords: Clinical pharmacokinetics, clinical studies, herbal hepatotoxicity, Polygonum multiflorum Thunb., therapeutic assessment
INTRODUCTION
Plants, herbs, and ethnobotanicals have been selected and used empirically equally drugs for centuries, initially as traditional preparations and then as pure active principles, with the knowledge and accumulated practise passing from generation to generation.[1,2] Medicinal plants are plants containing the substance that are used for therapeutic purposes or which are precursors for the synthesis of useful drugs.[three] Herbal Medicinal can be categorized into two broad parts. The commencement one includes complex of mixture containing a wide variety of compounds (eastward.g.: Infusions, essential oils, tinctures or extracts), and the 2nd category refers them as pure, chemically define agile principles.[iv]
Polygonum multiflorum Thunb. (PMT, Polygonaceae family unit, Figure 1)), well known equally He shou wu in Cathay and Fo-ti in North America,[5] is one of the most pop perennial Chinese traditional medicinal vine-similar herbs, officially listed in the Chinese Pharmacopoeia.[6] Various parts of the plants were utilized for dissimilar medicinal purposes. The leaves [Figure 2a], root tuber [Figure 2b] and rhizomes [Effigy 2c] of this plant have been used as tonic and anti-aging agents[7,8,nine,ten,11,12] whereas the stalk [Effigy 2nd] is used to alleviate insomnia and even to have an antidiabetic therapeutic activity also.[13,xiv,15]
Polygonum multiflorum Thunb
Photos of (a) leaves, (b) tuber roots, (c) underground rhizomes and (d) stem from Polygonum multiflorum Thunb
Laboratory studies and clinical practice have demonstrated that PMT possesses various biological and therapeutic actions, including anti-tumor,[sixteen,17] antibacterial,[18] anti-inflammatory,[13] anti-oxidant,[19,xx,21] anti-HIV,[22] liver protection,[23,24] nephroprotection,[25] antidiabetic,[15,26] anti-baldness,[27,28] and anti-atherosclerotic activities.[29,thirty] It has been too reported to exert preventive action confronting neurodegenerative diseases,[31,32,33,34,35] cardiovascular diseases and to reduce hyperlipidemia as well.[36,37]
The clinical efficacy, besides as the safety of PMT and its bioactive products, has attracted much attention in the recent years; due to the increasing reports of various cases on hepatotoxicity,[38,39,40,41,42] published worldwide. In the nowadays review, the advancements in thorough investigation of clinical studies and pharmacokinetics (PKs)-pharmacodynamics (PDs) profile of P. multiflorum are discussed, meanwhile describing the clinical features of this particular herbal-induced liver injury. This study will enlighten the wide understanding on the clinical therapeutic evaluation of PMT or other herbal drug containing quite the same phytochemical components.
METHODOLOGY
An electronic search was performed past searching several databases: PubMed (Medline), Highwire, HerbMed, Google Scholar, Scopus, Cochrane Database of Systematic Reviews and Cochrane Library using cardinal terms including, "PMT," "He shou wu," "Shou-Wu-Pian," "Shen-Min," "Fo-Ti," and "clinical written report," "humans," "patients," "case written report," "hepatotoxicity" to identify English language-linguistic communication publications (case reports, instance series, prospective study and clinical review manufactures) and abstracts published regarding P. multiflorum and/or its compounds. Furthermore, nosotros scanned the references lists of the master articles to identify the publications not retrieved past electronic research. A total of 54 publications were identified, and the results compiled. They showed 7 articles relevant to clinical PKs-PDs assay, 2 to anti-inflammatory effect, 2 for dyslipidemia handling, 2 relevant to sleep disorders, iii for neurodegenerative diseases and 52 patients with hepatotoxicity due to P. multiflorum ingestion. The quality of clinical studies on P. multiflorum, the characteristics and outcomes of patients reported with herbal hepatotoxicity and the P. multiflorum claimed pharmaco-therapeutic values are reviewed and discussed in this paper.
CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS STUDIES OF POLYGONUM MULTIFLORUM EXTRACTS AND/OR ITS BIOACTIVE COMPONENTS
Herbal medicines are mixtures of more one active ingredient. The multitude of pharmacologically active compounds obviously increases the likelihood of interactions taking place. Hence, the likelihood of herb-drug interactions is theoretically college than that of drug-drug interactions, if only because constructed drugs normally contain unmarried chemical entities.[43] Case reports and clinical studies have highlighted the beingness of a number of clinically of import interactions, although cause-and-effect relationships have not always been established. Herbs and drugs may interact either pharmacokinetically or pharmacodynamically [Figure 3].[44]
Schematic representation of the physiologic processes determining drug disposition in the human body and the relationship of pharmacokinetics and pharmacodynamics to these processes (A: Administration, D: Distribution, M: Metabolism, Eastward: Excretion)
To date, a number of in vitro studies have addressed the potential of selected herbal extracts and/or specific constituents to inhibit or induce drug-metabolizing enzymes or transporters, particularly cytochrome P450 (CYP450) isoforms and P-glycoprotein (P-pg). However, translation of in vitro data in a clinical setting is hard to achieve, and discrepancies are oftentimes observed between predicted outcomes on the footing of the in vitro studies and results of controlled clinical studies.[45]
Several pharmacological and clinical studies have been done to investigate the PK-PD parameters analyzes of PMT and/or its bioactive components. In 2002, some Korean scientists conducted a clinical PK report about rhein; ane of the principal bioactive of PMT.[46] This research produced some interesting findings, enlightening that in terms of the bioavailability, while the levels in aloe-emodin, emodin, and chrysophanol [Effigy 4] in herbal extracts were much higher than rhein level, only rhein was selectively absorbed past the trunk even if rhein is structurally similar to other anthraquinones.[46] These findings corroborate the results of some other clinical report published a decade earlier by Krumbiegel and Hu.[47] This phenomenon can be explained by one of the three following possibilities. The first one is that rhein are formed when sennosides (eastward.g.: Sennoside A, Figure v) are decomposed by bacteria in the intestines,[48] but the time courses of plasma rhein concentrations render this possibility highly improbable. The 2nd possibility is that sennosides are metabolized by abdominal bacteria into anthrones [Effigy 6], and the sulfoconjugation or glucoronidation occurs leading to the excretion of the substance through urine.[46] The third possibility stressed out the fact that rhein tin exist easily bio-transformed from aloe-emodin.[47,49] Furthermore, in another clinical investigation, the high bioavailability of rhein was assessed using the routes of administration as comparative key of the research. The findings suggested that after a single dose of herbal excerpt, the oral bioavailability of rhein was significantly higher than its rectal bioavailability.[50] By analysis of the route administration, the absorption of weak acids such as rhein may be optimal in the acidic environment of the tummy, whereas their assimilation might exist unfavorable in the relatively alkaline metal situation of the pocket-size intestine. Retention enema therapy requires multiple, higher daily doses due to poor bioavailability if the same plasma rhein concentration as oral therapy is to exist achieved.[fifty]
Chemical structures of aloe-emodin, chrysophanol, danthron, emodin, physcion and rhein
Chemic structure of sennoside A
Chemical construction of anthrones
Herbal medicines constituents may impact the part of the drug-metabolizing enzymes by inhibiting through dissimilar, yet not completely disclosed mechanisms, the catalytic activity of specific enzymes, or they may simply compete for bounden. In either case, increment in oral bioavailability and/or reduction of hepatic clearance of the affected drugs are expected to occur, thus leading to an increase in the plasma drug levels, which may expose the patient to a serious take a chance of adverse drug toxicity.[45] The drug transporters and drug-metabolizing enzymes involved in the in vivo process, the modulatory effects on both P-pg[51,52,53] and CYP450 isoenzymes[54,55] and the acute toxicity[39,56,57,58,59,60] of PMT and/or its major bioactive compounds are all well documented. P-gp-based drug interactions are a major business in the clinic and in preclinical drug development, especially with respect to the intestinal assimilation of drugs and distribution of drugs across the liver, kidney, intestine and blood-brain barrier.[61] Despite the widespread use of herbal medicines, documented herb-drug interactions are spare. However, studies on common herbs bespeak that meaning herb-drug interactions exists.[62] Several unremarkably used traditional Chinese medicine (TCM) have been reported to interact with P-gp. For example, St. John'due south wort was found to increase the duodenal P-gp expression past i.4-fold in healthy volunteers after multiple oral administrations. It was as well reported that St. John's wort could result in an 18% subtract of digoxin exposure after a single oral dose of digoxin (0.5 mg).[53,63] Li et al. investigated the inhibitory effect of PMT constituents on P-pg mediated the digoxin ship in MDR1-MDCKII cells. The herbal constituents tested were trans-Resveratrol [Effigy vii], 2,three,5,four'-tetrahydroxylstilbene-2-O-β-D-glucoside (TSG, Figure 8), emodin, chrysophanol, aloe-emodin, and physcion. Among the various constituents of P. multiflorum tested, emodin was significantly the strongest inhibitor of P-gp (ICfifty= nine.42 μM) in MDR1-MDCKII and Caco-2 cells.[53] Furthermore, clinical written report findings aware emodin to be found to possess the strongest promising effect for overcoming P-gp mediated steroid resistance by inhibiting the P-gp efflux function.[51]
Chemical structure of trans-resveratrol
2,3,5,4'-tetrahydroxylstilbene-2-O-β-D-glucoside
Genetic polymorphisms in the CYP450 enzyme likewise contribute to differences in an private'south ability to metabolize herbal medicines. The utilise of concurrent medications that either inhibit or induce ane or more isoforms, which may event in pregnant changes in the rate of drug clearance, is ane of the major reason for altered CYP450 activity.[44,64] CYP450 1A2 (CYP1A2) and CYP450 3A4 (CYP3A4) are involved in the metabolism of xenobiotic in the torso,[65,66] their expression appear to be induced by various herbal medicines and/or dietary constituents.[67] The genotype and the allelic frequencies of CYP1A2 were evaluated in Chinese patients with astute liver injury induced by P. multiflorum in gild to investigate CYP1A2 allele polymorphism association with the hepatotoxicity from PMT.[55] The findings revealed that the frequency of the CYP1A2 * 1C mutation in Chinese patients with P. multiflorum-induced acute liver injury differed significantly from that in healthy Chinese people, indicating that CYP1A2 * 1C is probably related to metabolism of PMT, which is, followed past acute liver injury.[55] Moreover, despite the structural similarity and/or identical molecular weight of various herbal constituents, emodin pregnant inhibited CYP3A4/5 activity.[53] Considering P. multiflorum and/or its constituents as relative toxic compound, potential drug-herb/herb-herb interactions based on CYP and P-gp should be taken into account when using this herbal medicine in the dispensary. By fully appreciating the nature of PKs, PDs principles, and drug-herb interactions, healthcare professionals tin can drastically reduce unwanted side effects and at the same time enhance the therapeutic efficacy and usefulness of herbal medicines.
CLINICAL STUDIES Done ON POLYGONUM MULTIFLORUM AND/OR ITS BIOACTIVE COMPOUNDS
In general, audio scientific evidence is defective to support the use of many of the herbs currently marketed. A number of herbal products rely on anecdotal evidence to support their employ. Many of the clinical trials in the literature are of limited quality owing to small sample sizes, improper randomization, and/or the lack of adequate controls. Large-scale, randomized, controlled trials have non been undertaken past the herbal industry owing to the fact that herbs are not patentable, and the potential of economical proceeds from positive written report results is limited. A number of researchers and organizations (east.g. Cochrane collaboration) have attempted to critically evaluate available study data through systematic reviews and meta-analyses. Many of the analyses have been equivocal.[68] The use of herbal medicines presents unique clinical and pharmacological challenges not encountered with conventional single-compound medicines. These medicines are usually complex mixtures of many bioactive compounds and conventional "indications and uses" criteria devised for unmarried-chemical compound entities may not be applicative in a significant number of ways.[69]
Few clinical studies accept been conducted to evaluate the traditional therapeutic claims and to study the potential of PMT and/or its various bioactive constituents, highlighting available clinical evidence.
Anti-inflammatory bioactivity
Inflammation is known to contribute to physiological and pathological processes by the activation of the immune system, local vascular system, and various cells inside the damaged tissue.[seventy] Prolonged inflammation, known every bit chronic inflammation, is caused by a variety of factors, including microbial pathogen infection, physical, chemical, and surgical irritation, and/or wounding and information technology is involved in the pathogenesis of various many chronic diseases, including inflammatory bowel diseases, rheumatoid arthritis, sepsis, and cancer.[71,72,73,74] The classical characteristics of inflammation are hurting, swelling, edema, redness, and heat.[75] Accumulating epidemiological, and clinical evidence shows that chronic inflammation is an of import gamble gene for various human diseases.[76] Therefore, suppressing the production of pro-inflammatory molecules and signaling factors is one of the important target pathways in order to forbid or care for diverse diseases.
Various natural products from TCM take been shown to safely suppress pro-inflammatory pathways and control inflammation-associated disease. In vivo and/or in vitro studies have demonstrated that anti-inflammatory furnishings of PMT and/or its bioactive constituents occur past inhibition of the expression of pro-inflammatory signaling factors such as nuclear factor-κB, tumor necrosis gene-α, inducible nitric oxide synthase, cyclooxygenase-2, chemokines (east.1000.,: CCL2) and cytokines (east.g.: Interleukin-i beta).[13,52,74,77] P. multiflorum was significantly tested for the treatment of the localized neurodermatitis by plum-blossom needle taping in a clinical study that enrolled 141 patients.[78] Moreover, STD07 (Physcion) adult by Lord's day Tem Phytotech for the treatment of inflammatory bowel diseases, was evaluated in a randomized, double-blind, single-centered and placebo controlled report in Asian good for you volunteers.[79] The authors found that upward to 250 mg/mean solar day orally for 14 days; STD07 was full general well tolerated with no clinically meaningful adverse effects in healthy volunteers in this Phase I clinical trial. Expert therapeutic evidences of P. multilforum and/or its bioactive constituents accept been shown in these aforementioned clinical studies to be used equally anti-inflammatory agents. However, extensive clinical enquiry is needed concerning the therapeutic value of this herbal medicine on its anti-inflammatory activity.
Dyslipidemia
The hepatocytes play important function in the distribution, biosynthesis, transferring and removal of triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL) and other related lipoproteins.[lxxx] In normal human liver, the hateful contents of TC and TG are three.nine and nineteen.5 mg/1000 wet weight, respectively. Traditionally, liver fat content >l mg/g (5% past wet weight) is diagnostic of hepatic steatosis.[81] Dyslipidemia, defined as any abnormality of serum lipids and lipoproteins, including depression levels of HDL-cholesterol that is associated with increased coronary heart diseases (CHD) risk, is a substantial correspondent to the incidence of CHD.[37] In developed countries, most dyslipidemias are hyperlipidemias; that is, an summit of lipids in the claret. This is often due to diet and lifestyle. Prolonged elevation of insulin levels can also lead to dyslipidemia. Similarly, increased levels of O-GlcNAc transferase may cause dyslipidemia. Dyslipidemia can be treated with dietary alterations and medications that affect lipid metabolism via a variety of mechanisms.[82] Being the first-line therapies for reducing LDL-C serum levels, statins as well have adverse effects, including muscle myopathy and derangements in hepatic office.[83] Fibrates are second-line drugs that are used for the handling of dyslipidemia and reduce serum TG levels by activating peroxisome proliferator-activated receptor blastoff. However, fibrates increase serum creatinine concentrations[84] and accept been correlated with sudden death, pancreatitis, and venous thrombosis.[85]
Traditional Chinese medicine plays a very important role in the treatment of dyslipidemic patients.[86] An early uncontrolled clinical study of 50 hyperlipidemic patients suggested that PMT has lipid-lowering result which may be related to its regulatory effect on the genes involved in cholesterol synthesis and lipoprotein metabolism.[87] In a very recent randomized, double-bullheaded, placebo-controlled clinical trial, the therapeutic effect of P. multiflorum in patients with dyslipidemia was investigated.[88] The findings concluded that being a considerable composition of the multiherb formula, P. multiflorum showed marginal beneficial event on reducing plasma LDL cholesterol levels in patients with dyslipidemia. In order to validate the claimed dyslipidemia therapeutic activeness of P. multiflorum and/or its bioactive compounds, further well-designed clinical studies with solid bear witness are warranted to investigate this mechanism.
Slumber disorders
Indisposition or sleeplessness is a slumber disorder in which there is an inability to fall comatose or to stay comatose as long as desired.[89] It is prevalent in woman and the elderly by 40% more common in women than in men.[90,91] Different measures, such as pharmacotherapy and behavioral management, are applied for insomnia and associated complaints.[92] Electric current indisposition pharmacotherapeutic agents mainly target the γ-aminobutyric acid (GABA) receptor, melatonin receptor, histamine receptor, orexin, and serotonin receptor. GABA receptor modulators are ordinarily used to manage insomnia, only they are known to affect sleep maintenance, including residual furnishings, tolerance, and dependence.[91] An analysis of the United states of america National Health Interview Survey data from 2002 by Pearson et al.[133] revealed that of the 17.four% of adults (n = 93 386) reporting insomnia or regular sleep disturbance in the preceding month, four.5% (of that population) used complementary and alternative medicine to improve their sleep.
In an effort to discover new drugs that relieve indisposition symptoms while avoiding side effects, numerous studies focusing on the neurotransmitter GABA and herbal medicines have been conducted. Several traditional herbal medicines, such as Valeriana officinalis,[93,94] Passiflora incarnata,[95,96] Matricaria recutita L.,[97,98] Humulus lupulus,[99,100] Ginkgo bibola,[101] Centella asiatica,[102] Rhodiola rosea,[103] Hypericum perforatum,[104] Piper methysticum[105,106] and Zizyphus jujuba[14] have been widely clinically reported to improve sleep and other mental disorders. Moreover, recently Wuling capsule, a single herb formula from mycelia of precious Xylaria nigripes was investigated for its efficacy and safety, through a multicenter, randomized, double-bullheaded, placebo-controlled trail, in Chinese patients with indisposition.[107] The clinical findings claimed that Wuling sheathing could considerably improve insomnia and in terms of adverse outcome, on a-vi weeks written report period the drug was well-tolerated by all the patients.
In the first big-calibration survey done in Taiwan of the use of Chinese herbal medicines (CHMs) or the treatment of indisposition in a Chinese population, P. multiflorum was found to be the most commonly prescribed single Chinese herb.[14] Furthermore, amidst the Chinese herbal formulas used to treat indisposition, P. multiflorum was found significantly an important elective of the ingredients. Although Shou-wu-teng (P. multiflorum) is often used to care for indisposition during clinical practice, no clinical inquiry exists in the Western literature verifying its sedative or anxiolytic effects.[14] Despite limited evidence from currently available studies, herbal medicines, especially P. multiflorum and/or its bioactive compounds may have beneficial effects on anxiety and indisposition in patients with bipolar disorder.[108]
Anti-insomniac phytotherapy opens upward an exciting aspect of research which might do good a big number of patients suffering from different degrees of insomnia. Futurity research using CHM for sleep disorders requires further rigorous studies with improved methodological design, such as using an appropriate placebo control, double-blinding, validated outcome scales, and longer follow-upward periods.[109] There is a need for more PD and PK studies to examine the mechanism of activeness, dosage regimen, toxicology and adverse effects, if at that place are whatsoever drug interactions and the epigenetic differences afflicted between unmarried active constituents versus whole extracts and circuitous prescriptive formulas.[109,110] In order to avoid location bias, as nearly all these studies are conducted in Red china, other countries are too encouraged further to pursue CHM clinical studies in the treatment of sleep disorders.[112]
Neurodegenerative affliction
Age is the leading risk factor for acute and chronic neurodegenerative diseases such as Parkinson's disease (PD), stroke, Huntington's disease (Hard disk drive), vascular dementia (VaD) and Alzheimer's affliction (Advertisement), etc., As population aging is occurring on a global scale, the incidence of these diseases is likely to increase significantly in the near future.[111] They show common pathology of aggregation and degradation of abnormal protein. For example, deposit of Aβ and tau in Advertising,[112] α-Synuclein for Parkinson'southward disease,[113] huntingtin protein in HD,[114] transactive response Dna-binding protein 43 in frontotemporal dementia and amyotrophic lateral sclerosis.[115] Neurodegenerative diseases normally have the symptoms of loss of orientation, spoken language, comprehension and learning abilities. To appointment, there is a lack of constructive preventive strategies for these disorders. Furthermore, treatments are mainly symptomatic and tin at best temporarily slow down disease progression.[111] Moreover, lack of treatment options has led to an increasing number of people to use "natural" and herbal medicines in an attempt to prevent or delay the deleterious effects of ageing as longevity and good health have always been desirable goals for humans.
Various herbal medicines and/or their bioactive compounds accept been establish to exert significant therapeutic upshot in vitro model of neurodegenerative diseases. Pharmacological studies of PMT excerpt claimed that this medicinal establish may exist beneficial in preventing PD[31] and Advertising.[nine] Furthermore, TSG [Effigy 8], one of the bioactive compounds purified from its roots significantly antagonized age-related α-synuclein overexpression in the hippocampus of APP transgenic mouse model of AD[116] and possessed neuroprotection in the 1-Methyl-four-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson'southward disease.[35] Ginkgo biloba and Lycopodium serratum (Huperzine A), through diverse randomized, double-bullheaded, placebo-controlled, parallel and multi-center clinical trials accept been assessed for their clinical efficacy and safety in AD handling.[117,118] Their claimed neuroprotective therapeutic activity was significantly expressed on balmy AD clinical cases.
Few clinical trials have investigated the potential therapeutic activity of PMT in neurodegenerative diseases. Chen et al. observed the clinical effect of PMT extract on Advert.[119] The findings suggested that the scores for the Mini-Mental Country Examination and the Power of Daily Living Calibration were significantly improved in the treatment group compared to the Chinese herb control grouping and the western medicine command grouping (P < 0.01). Moreover, in a randomized, Piracetam-controlled, unmarried-center clinical trial, P. multiflorum (Shouwu yizhi capsule) was evaluated as monotherapy for VaD.[120] The authors found that the total clinical effective rate was 71.25% and that the herbal medicinal had obvious therapeutic result on VaD, with no relative agin drug reactions.
DCB-AD1 is a new drug derived from PMT and a medical squad in Taiwan is proposing a Phase II double-bullheaded, randomized, placebo-controlled and parallel clinical trial to assess its efficacy and safe in patients with balmy to moderate AD.[121] Nosotros therefore believe that further high quality clinical studies on PMT and its isolated bio-compounds, besides equally the herbal mixtures resulted, will appraise its actual clinical value and could lead to the discovery of new drugs for constructive treatment and prevention of neurodegenerative diseases.
CLINICAL CASES OF POLYGONUM MULTIFLORUM-INDUCED HEPATOTOXICITY
Herbal medicines are mostly sold as food supplements, and as a consequence, therapeutic indications, efficacy, and safety are influenced by different opinions, according to the clinical or traditional experience of diverse folk medicines bachelor in each land.[122] The market regulation of herbal medicines is not harmonized considering in that location are different regulations in European, Asian and Northward American countries, and every bit a issue, this lack of rules gives poor guarantee of clinical safety.[123] Many herbal products have been shown to cause astringent toxicity, but, despite the potential toxicity, at that place is widespread use among eastern and western full general population. Information on clinical issues of herbal medicines are scarcely available and even if they have been reported, unlike what happens full general practitioners may not be fully informed since correct utilize and rubber of herbal medicinal products is not taught past academic institutions in medicine faculties.[124] The current situation requires the cognition, recognition and monitoring of adverse reactions through pharmacovigilance activities.
Herbal hepatotoxicity or herb-induced liver injury is rare and represents a packet of disorders, each characterized by a specific herb or herbal mixture considered as potentially hepatotoxic.[125] Whatever individual herb with its multiple chemical constituents may target different liver cell types and/or different subcellular structures, causing likely unlike diagnostic markers for potentially hepatotoxic herbs and injury types with no unmarried marker characteristic for herbal liver impairment.[126] P. multiflorum (Shou-Wu-Pian and Shen-Min have been the most-well known products), existence one of the most famous Chinese herbs to treat several diseases and medical atmospheric condition including dizziness with tinnitus, premature greying of hair, lumbago, spermatorrhea, leucorrhea, constipation and even chronic hepatitis B,[38,59,127] has also been ranked in the top 5 of individual herbs or used near frequently in TCM formulations to induce hepatotoxicity.[128] Several cases of hepatotoxicity due to PMT have been reported in patients from Australia, China, Italian republic, Japan, The Netherlands and Slovakia taking the product for hair loss, chronic prostatitis and to boost the immune system.[38,39,xl,58,60,129]
The patients had a history of having ingested PMT in diverse forms (tea boil with PMT, liquor made of PMT, honey-soaked out with PMT, and the powder of dried PMT). Withal, information technology raised the issue concerning the course of the intake with the relation to the severity of hepatotoxicity.[59] The processed roots of PMT have displayed lower rates of toxicity as reported in animal experiments.[130] Processing appears to significantly reduce the corporeality of chemicals like 2,3,4′5-tetrahydroxystilbene-2-O-β-Dglucoside, but it remains to be adamant if this can explain reduced toxicity in humans. For raw PMT, the toxicity of water decocta appears to be higher than that of acetone extract. Meanwhile, the toxicity of acetone excerpt of unprocessed PMT is considerably college than that of acetone extract of processed PMT. Loftier-performance liquid chromatography analyses and nuclear magnetic resonance analysis revealed that the contents of characteristic compounds in raw PMT were changed subsequently processing: The content of 2,3,4Ͳ,5-tetrahydroxystilbene two-O-β-D-glucoside was decreased by 55.8%, whereas the content of anthraquinone emodin was increased by 34.0%.[40,130] Thus, suggesting that processing should reduce the toxicity of P. multiflorum.
Determination
Plants have been selected and apply empirically every bit drugs for centuries, initially as traditional preparations then equally pure active principles, with the knowledge and accumulated practice passing from generation to generation.[i] Herbal medicine, phytotherapy, phytomedicine, complementary and alternative medicine, ethnomedicine, herbal medicinal product and dietary supplements are all terms used interchangeably to denote the apply of botanicals in healthcare and are therefore used as such in this text.[131] The human population is a total mixture, dissimilar selected batches of laboratory animals (same age, weight, sexual practice, strain, etc.). For this reason, human being beings exercise not reply uniformly to i or more than drugs or fifty-fifty herbal medicines. Our genetic make-up, ethnic groundwork, sex, renal and hepatic functions, diseases and nutritional states, ages and other factors such as the route of administration, all contribute toward the heterogeneity of our responses.[132]
Pharmacological studies have demonstrated that PMT. extracts and/or its isolated pure compound possessed diverse biological activities such every bit anti-bacterial, anti-inflammatory, anti-diabetic, anti-cancer, anti-oxidant and exerting preventing activity against neurodegenerative diseases as well. Clinical investigations have enlightened its claimed therapeutic action in anti-inflammatory, dyslipidemia, sleep disorders and neurodegenerative diseases. A general lack of knowledge of the interaction potentials of concurrent employ of herbal medicines with prescription and/or over-the counter medicines poses a great challenge for health care professional and safety business for the patients. In the recent years, due to increasing reports of herbal-induced hepatotoxicity, the clinical efficacy and safety of P. multiflorum and/or its isolated compounds have attracted much interest. The clinical presentation and severity of P. multiflorum tin be highly variable, ranging from mild hepatitis to acute hepatitis failure requiring transplantation.
Pharmacists and technicians, every bit well as physicians, dieticians, and other health care providers must become knowledgeable virtually herbal supplements and prospectively seek information regarding their patients' use of unconventional medicines to avoid agin consequences. Consumers need to be reminded that herbs are equanimous of chemicals that may, in some cases be toxic, especially if large quantities are ingested. Furthermore, much developed countries and scientific societies are encouraged to conduct clinical studies on P. multiflorum and/or its isolated compounds in order to evaluate their claimed therapeutic activities.
Footnotes
Source of Support: Nil.
Conflict of Interest: None declared.
REFERENCES
ane. Taylor JL, Rabe T, McGraw LJ, Jäger AK, van Staden J. Towards the scientific validation of traditional medicinal plants. Plant Growth Regul. 2001;34:23–37. [Google Scholar]
two. Wachtel-Galor S, Benzie IF, editors. Herbal Medicine: Biomelecular and Clinical Aspect. 2d ed. Florida: CRC Printing; 2011. Herbal medicine: An introduction to its history, usage, regulation, current trends, and inquiry needs; pp. 1–ten. [Google Scholar]
iii. Abolaji OA, Adebayo AH, Odesanmi Bone. Nutritional qualities of three medicinal plants parts (Xylopia aethiopica, Blighia sapida and Parinari polyandra) commonly used past significant women in the western role of Nigeria. Pak J Nutr. 2007;6:655–viii. [Google Scholar]
4. Hamburger M, Hostettman 1000. Bioactivity in plants: The link between phytochemistry and medicine. Phytochemistry. 1991;thirty:3864–74. [Google Scholar]
5. Lv L, Shao 10, Wang L, Huang D, Ho CT, Sang South. Stilbene glucoside from Polygonum multiflorum Thunb.: A novel natural inhibitor of advanced glycation end product formation by trapping of methylglyoxal. J Agric Nutrient Chem. 2010;58:2239–45. [PubMed] [Google Scholar]
6. 1st Div. Beijing: China Chemical Industry Printing; 2010. Pharmacopoeia Committee of the Ministry of Health. Pharmacopoeia of the People's Commonwealth of China (PPRC) pp. 22–3. [Google Scholar]
7. Grech JN, Li Q, Roufogalis BD, Duck CC. Novel Ca (2+)-ATPase inhibitors from the dried root tubers of Polygonum Multiflorum. J Nat Prod. 1994;57:1682–seven. [PubMed] [Google Scholar]
8. Kam JK. Mutagenic activity of Ho Shao Wu (Polygonum multiflorum Thunb) Am J Chin Med. 1981;ix:213–5. [PubMed] [Google Scholar]
ix. Um MY, Choi WH, Aan JY, Kim SR, Ha TY. Protective effect of Polygonum multiflorum Thunb on amyloid beta-peptide 25–35 induced cognitive deficits in mice. J Ethnopharmacol. 2006;104:144–8. [PubMed] [Google Scholar]
10. Kwon BM, Kim SH, Baek NI, Lee SI, Kim EJ, Yang JH, et al. Farnesyl protein transferase inhibitory components of Polygonum multiflorum. Curvation Pharm Res. 2009;32:495–9. [PubMed] [Google Scholar]
eleven. Yang LJ. Inssussion on the application of pilus-blackening and hair growth accelerating effects of Polygonum multiflorum from ancient prescription. J Tradit Chin Med. 2008;7:39–40. [Google Scholar]
12. Guan S, Su W, Wang Due north, Li P, Wang Y. Effects of radix polygoni multiflori components on tyrosinase activity and melanogenesis. J Enzyme Inhib Med Chem. 2008;23:252–five. [PubMed] [Google Scholar]
xiii. Cha DS, Jeon H. Anti-inflammatory upshot of MeOH extracts of the stem of Polygonum multiflorum in LPS-stimulated mouse peritoneal macrophages. Nat Prod Sci. 2009;fifteen:83–9. [Google Scholar]
xiv. Chen FP, Jong MS, Chen YC, Kung YY, Chen TJ, Chen FJ, et al. Prescriptions of Chinese herbal medicines for indisposition in Taiwan during 2002. Evid Based Complement Alternat Med. 2011;2011:236341. [PMC free article] [PubMed] [Google Scholar]
xv. Wang H, Vocal Fifty, Feng Southward, Liu Y, Zuo 1000, Lai F, et al. Characterization of proanthocyanidins in stems of Polygonum multiflorum Thunb equally strong starch hydrolase inhibitors. Molecules. 2013;eighteen:2255–65. [PMC gratuitous article] [PubMed] [Google Scholar]
sixteen. Horikawa G, Mohri T, Tanaka Y, Tokiwa H. Moderate inhibition of mutagenicity and carcinogenicity of benzo[a] pyrene, 1,half dozen-dinitropyrene and 3,ix-dinitrofluoranthene by Chinese medicinal herbs. Mutagenesis. 1994;ix:523–6. [PubMed] [Google Scholar]
17. Choi SG, Kim J, Sung ND, Son KH, Cheon HG, Kim KR, et al. Anthraquinones, Cdc25B phosphatase inhibitors, isolated from the roots of Polygonum multiflorum Thunb. Nat Prod Res. 2007;21:487–93. [PubMed] [Google Scholar]
eighteen. Zuo GY, Wang GC, Zhao YB, Xu GL, Hao XY, Han J, et al. Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) J Ethnopharmacol. 2008;120:287–xc. [PubMed] [Google Scholar]
19. Ip SP, Tse AS, Poon MK, Kow KM, Ma CY. Antioxidant activities of Polygonum multiflorum Thunb. in vivo and in vitro. Phytother Res. 1997;eleven:42–4. [Google Scholar]
20. Chan YC, Wang MF, Chen YC, Yang DY, Lee MS, Cheng FC. Long-term administration of Polygonum multiflorum Thunb. reduces cognitive ischemia-induced infarct volume in gerbils. Am J Chin Med. 2003;31:71–vii. [PubMed] [Google Scholar]
21. Lv LS, Gu XH, Tang J, Ho CT. Antioxidant activeness of stilbene glycoside from Polygomum multiflorum Thunb. in vivo. Food Chem. 2007;104:1678–81. [Google Scholar]
22. Lin HW, Sun MX, Wang YH, Yang LM, Yang Year, Huang N, et al. Anti-HIV activities of the compounds isolated from Polygonum cuspidatum and Polygonum multiflorum. Planta Med. 2010;76:889–92. [PubMed] [Google Scholar]
23. Lee BH, Huang YY, Duh PD, Wu SC. Hepatoprotection of emodin and Polygonum multiflorum against CCl (4)-induced liver injury. Pharm Biol. 2012;50:351–ix. [PubMed] [Google Scholar]
24. Huang CH, Horng LY, Chen CF, Wu RT. Chinese herb Radix Polygoni Multiflori as a therapeutic drug for liver cirrhosis in mice. J Ethnopharmacol. 2007;114:199–206. [PubMed] [Google Scholar]
25. Guo XH, Liu ZH, Dai CS, Li H, Liu D, Li LS. Rhein inhibits renal tubular epithelial prison cell hypertrophy and extracellular matrix accumulation induced by transforming growth gene beta1. Acta Pharmacol Sin. 2001;22:934–viii. [PubMed] [Google Scholar]
26. Li CR, Cai F, Yang YQ, Zhao XY, Wang C, Li J, et al. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: Interest of SIRT1 and TGF-β1 pathway. J Ethnopharmacol. 2010;649:382–ix. [PubMed] [Google Scholar]
27. Park HJ, Zhang North, Park DK. Topical application of Polygonum multiflorum extract induces hair growth of resting hair follicles through upregulating Shh and ß-catenin expression in C57BL/6 mice. J Ethnopharmacol. 2011;135:369–75. [PubMed] [Google Scholar]
28. Seo SR, Kang G, Ha JW, Kim JC. In vivo hair growth-promoting efficacies of herbal extracts and their cubosomal suspensions. J Ind Eng Chem. 2013;19:1331–nine. [Google Scholar]
29. Yang PY, Almofti MR, Lu 50, Kang H, Zhang J, Li TJ, et al. Reduction of atherosclerosis in cholesterol-fed rabbits and decrease of expressions of intracellular adhesion molecule-ane and vascular endothelial growth factor in foam cells past a water-soluble fraction of Polygonum multiflorum. J Pharmacol Sci. 2005;99:294–300. [PubMed] [Google Scholar]
30. Zhang YZ, Shen JF, Xu JY, Xiao JH, Wang JL. Inhibitory furnishings of two,3,five,4'-tetrahydroxystilbene-two-O-beta-D-glucoside on experimental inflammation and cyclooxygenase 2 activity. J Asian Nat Prod Res. 2007;9:355–63. [PubMed] [Google Scholar]
31. Li X, Matsumoto Chiliad, Murakami Y, Tezuka Y, Wu Y, Kadota S. Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced past paraquat and maneb in mice. Pharmacol Biochem Behav. 2005;82:345–52. [PubMed] [Google Scholar]
32. Zhang L, Xing Y, Ye CF, Ai HX, Wei HF, Li L. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention past using tetrahydroxystilbene glucoside. Behav Brain Res. 2006;173:246–54. [PubMed] [Google Scholar]
33. Wang R, Tang Y, Feng B, Ye C, Fang Fifty, Zhang 50, et al. Changes in hippocampal synapses and learning-retentivity abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in anile rats. Neuroscience. 2007;149:739–46. [PubMed] [Google Scholar]
34. Liu LF, Durairajan SS, Lu JH, Koo I, Li Thousand. In vitro screening on amyloid precursor protein modulation of plants used in Ayurvedic and traditional Chinese medicine for retention improvement. J Ethnopharmacol. 2012;141:754–lx. [PubMed] [Google Scholar]
35. Zhang L, Huang L, Chen L, Hao D, Chen J. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's affliction. Toxicol Lett. 2013;222:155–63. [PubMed] [Google Scholar]
36. Liu QL, Xiao JH, Ma R, Ban Y, Wang JL. Effect of 2,3,v,4'- tetrahydroxystilbene-ii-O-beta-D-glucoside on lipoprotein oxidation and proliferation of coronary arterial smooth cells. J Asian Nat Prod Res. 2007;9:689–97. [PubMed] [Google Scholar]
37. Xie Due west, Zhao Y, Du 50. Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia. J Ethnopharmacol. 2012;140:345–67. [PubMed] [Google Scholar]
38. Park GJ, Mann SP, Ngu MC. Acute hepatitis induced past Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol. 2001;xvi:115–7. [PubMed] [Google Scholar]
39. Mazzanti G, Battinelli L, Daniele C, Mastroianni CM, Lichtner Grand, Coletta S, et al. New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Ann Intern Med. 2004;140:W30. [PubMed] [Google Scholar]
xl. Panis B, Wong DR, Hooymans PM, De Smet PA, Rosias PP. Recurrent toxic hepatitis in a Caucasian daughter related to the employ of Shou-Wu-Pian, a Chinese herbal preparation. J Pediatr Gastroenterol Nutr. 2005;41:256–8. [PubMed] [Google Scholar]
41. Cárdenas A, Restrepo JC, Sierra F, Correa G. Astute hepatitis due to shen-min: A herbal production derived from Polygonum multiflorum. J Clin Gastroenterol. 2006;40:629–32. [PubMed] [Google Scholar]
42. Cho HC, Min HJ, Ha CY, Kim HJ, Kim TH, Jung WT, et al. Reactivation of Pulmonary Tuberculosis in a Patient with Polygonum multiflorum Thunb-Induced Hepatitis. Gut Liver. 2009;iii:52–half dozen. [PMC gratuitous article] [PubMed] [Google Scholar]
43. Ebadi MS, editor. Pharmacodynamic Basis of Herbal Medicine. 2nd ed. Boca Raton, Flordia: CRC Press, Taylor and Francis; 2007. Herb-drug interactions; pp. 37–46. [Google Scholar]
44. Beelen AP, Lewis LD. Clinical pharmacology overview. In: Figg WD, McLeod HL, editors. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. New Jersey: Humana Printing; 2004. pp. 111–28. [Google Scholar]
45. Berliocchi L, Russo R, Mizoguchi H, Corasaniti MT. Mechanisms and clinical relevance of herb-drug interactions from the perspectives of pharmacokinetics. In: Bagetta K, Cosentino M, Corasaniti MT, Sakurada Due south, editors. Herbal Medicines: Development and Validation of Institute-Derived Medicines for Human being Health. Florida: CRC Press; 2012. pp. 243–78. [Google Scholar]
46. Lee JH, Kim JM, Kim C. Pharmacokinetic analysis of rhein in Rheum undulatum L. J Ethnopharmacol. 2003;84:five–9. [PubMed] [Google Scholar]
47. Krumbiegel G, Schulz HU. Rhein and aloe-emodin kinetics from senna laxatives in man. Pharmacology. 1993;47(Suppl 1):120–4. [PubMed] [Google Scholar]
48. De Witte P. Metabolism and pharmacokinetics of anthranoids. Pharmacology. 1993;1:86–97. [PubMed] [Google Scholar]
49. Xu F, Liu Y, Zhang Z, Song R, Dong H, Tian Y. Rapid simultaneous quantification of five active constituents in rat plasma past loftier-performance liquid chromatography/tandem mass spectrometry subsequently oral administration of Da-Cheng-Qi decoction. J Pharm Biomed Anal. 2008;47:586–95. [PubMed] [Google Scholar]
fifty. Zhu W, Wang XM, Zhang L, Li XY, Wang BX. Pharmacokinetic of rhein in healthy male volunteers following oral and memory enema assistants of rhubarb extract: A single dose study. Am J Chin Med. 2005;33:839–l. [PubMed] [Google Scholar]
51. Zhang B, Shi Y, Lei TC. Detection of active P-glycoprotein in systemic lupus erythematosus patients with poor affliction control. Exp Ther Med. 2012;4:705–x. [PMC costless article] [PubMed] [Google Scholar]
52. Choi RJ, Ngoc TM, Bae 1000, Cho HJ, Kim DD, Chun J, et al. Anti-inflammatory properties of anthraquinones and their relationship with the regulation of P-glycoprotein function and expression. Eur J Pharm Sci. 2013;48:272–81. [PubMed] [Google Scholar]
53. Li X, Hu J, Wang B, Sheng L, Liu Z, Yang South, et al. Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: Herb-drug interactions mediated via P-gp. Toxicol Appl Pharmacol. 2014;275:163–75. [PubMed] [Google Scholar]
54. Unger Thou, Frank A. Simultaneous conclusion of the inhibitory potency of herbal extracts on the action of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom. 2004;18:2273–81. [PubMed] [Google Scholar]
55. Ma KF, Zhang XG, Jia HY. CYP1A2 polymorphism in Chinese patients with astute liver injury induced by Polygonum multiflorum. Genet Mol Res. 2014;xiii:5637–43. [PubMed] [Google Scholar]
56. But PP, Tomlinson B, Lee KL. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum. Vet Hum Toxicol. 1996;38:280–2. [PubMed] [Google Scholar]
57. Yuen MF, Tam S, Fung J, Wong DK, Wong BC, Lai CL. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: A 1-year prospective report. Aliment Pharmacol Ther. 2006;24:1179–86. [PubMed] [Google Scholar]
58. Furukawa M, Kasajima S, Nakamura Y, Shouzushima Thou, Nagatani N, Takinishi A, et al. Toxic hepatitis induced by show-wu-pian, a Chinese herbal preparation. Intern Med. 2010;49:1537–forty. [PubMed] [Google Scholar]
59. Jung KA, Min HJ, Yoo SS, Kim HJ, Choi SN, Ha CY, et al. Drug-induced liver injury: Xx five cases of acute hepatitis following ingestion of Polygonum multiflorum Thunb. Gut Liver. 2011;5:493–ix. [PMC free commodity] [PubMed] [Google Scholar]
60. Dong H, Slain D, Cheng J, Ma W, Liang W. Eighteen cases of liver injury post-obit ingestion of Polygonum multiflorum. Complement Ther Med. 2014;22:70–4. [PubMed] [Google Scholar]
61. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A. 1987;84:7735–8. [PMC free article] [PubMed] [Google Scholar]
62. Izzo AA, Ernst E. Interactions betwixt herbal medicines and prescribed drugs: A systematic review. Drugs. 2001;61:2163–75. [PubMed] [Google Scholar]
63. Dürr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, et al. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther. 2000;68:598–604. [PubMed] [Google Scholar]
64. Sekine I, Saijo North. Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents. Ann Oncol. 2001;12:1515–25. [PubMed] [Google Scholar]
65. Gibbs MA, Thummel KE, Shen DD, Kunze KL. Inhibition of cytochrome P-450 3A (CYP3A) in human being abdominal and liver microsomes: Comparing of Ki values and impact of CYP3A5 expression. Drug Metab Dispos. 1999;27:180–7. [PubMed] [Google Scholar]
66. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics. 2004;14:one–eighteen. [PubMed] [Google Scholar]
67. Fontana RJ, Lown KS, Paine MF, Fortlage L, Santella RM, Felton JS, et al. Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology. 1999;117:89–98. [PubMed] [Google Scholar]
68. Ashar BH, Dobs Equally. Clinical trials for herbal extracts. In: Packer Fifty, Ong CN, Halliwell B, editors. Herbal and Traditional Medicine: Molecular Aspect of Wellness. New York: Marcel Dekker; 2004. pp. 53–72. [Google Scholar]
69. Yong EL, Loh YS. Herbal medicines: Criteria for use in health and affliction. In: Packer L, Ong CN, Halliwell B, editors. Herbal and Traditional Medicine: Molecular Aspect of Health. New York: Marcel Dekker; 2004. pp. 73–86. [Google Scholar]
71. Ljung T, Lundberg South, Varsanyi One thousand, Johansson C, Schmidt PT, Herulf M, et al. Rectal nitric oxide as biomarker in the handling of inflammatory bowel disease: Responders versus nonresponders. World J Gastroenterol. 2006;12:3386–92. [PMC free article] [PubMed] [Google Scholar]
72. Park MY, Kwon HJ, Sung MK. Evaluation of aloin and aloe-emodin as anti-inflammatory agents in aloe by using murine macrophages. Biosci Biotechnol Biochem. 2009;73:828–32. [PubMed] [Google Scholar]
74. Pan MH, Chiou YS, Tsai ML, Ho CT. Anti-inflammatory activity of traditional Chinese medicinal herbs. J Tradit Complement Med. 2011;1:8–24. [PMC gratis article] [PubMed] [Google Scholar]
75. Mantovani A. Molecular pathways linking inflammation and cancer. Curr Mol Med. 2010;10:369–73. [PubMed] [Google Scholar]
76. Khatami Grand. Inflammation, aging, and cancer: Tumoricidal versus tumorigenesis of amnesty: A mutual denominator mapping chronic diseases. Cell Biochem Biophys. 2009;55:55–79. [PubMed] [Google Scholar]
77. Meng G, Liu Y, Lou C, Yang H. Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-κB activation by disrupting lipid rafts in CD14-negative endothelial cells. Br J Pharmacol. 2010;161:1628–44. [PMC costless article] [PubMed] [Google Scholar]
78. Weiying L, Yuanjiang D, Baolian L. Treatment of the localized neurodermatitis by plum-blossom needle tapping and with the modified yangxue dingfeng tang - A clinical observation of 47 cases. J Tradit Chin Med. 2006;26:181–3. [PubMed] [Google Scholar]
79. Tzeng TB, Chang WK, Huang TY, Wu PT, Huang WC, Lee C, et al. Prophylactic and tolerability of physcion in healthy volunteers in a phase I dose escalating clinical pharmacology report. Gastroenterology. 2011;140:S572. [Google Scholar]
eighty. Wang M, Zhao R, Wang Due west, Mao Ten, Yu J. Lipid regulation effects of Polygoni multiflori Radix, its processed products and its major substances on steatosis human liver cell line L02. J Ethnopharmacol. 2012;139:287–93. [PubMed] [Google Scholar]
81. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy Southward, et al. Magnetic resonance spectroscopy to mensurate hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462–eight. [PubMed] [Google Scholar]
82. Toth PP. Drug treatment of hyperlipidaemia: A guide to the rational utilize of lipid-lowering drugs. Drugs. 2010;70:1363–79. [PubMed] [Google Scholar]
83. Maggo SD, Kennedy MA, Clark DW. Clinical implications of pharmacogenetic variation on the effects of statins. Drug Saf. 2011;34:1–19. [PubMed] [Google Scholar]
84. Jun Chiliad, Foote C, Lv J, Neal B, Patel A, Nicholls SJ, et al. Furnishings of fibrates on cardiovascular outcomes: A systematic review and meta-analysis. Lancet. 2010;375:1875–84. [PubMed] [Google Scholar]
85. Wierzbicki Equally. Fibrates in the treatment of cardiovascular chance and atherogenic dyslipidaemia. Curr Opin Cardiol. 2009;24:372–9. [PubMed] [Google Scholar]
86. Dou XB, Wo XD, Fan CL. Progress of inquiry in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine. Mentum J Integr Med. 2008;14:71–5. [PubMed] [Google Scholar]
87. Ke SL, Xie RG, Zheng WR, Xie J. Clinical observation of Polygonum multiflorum in Deqing in handling of hyperlipidemia. Guang Dong Yi Xue. 2000;21:977–8. [Google Scholar]
88. Hu K, Zeng Due west, Tomlinson B. Evaluation of a crataegus-based multiherb formula for dyslipidemia: A randomized, double-blind, placebo-controlled clinical trial. Evid Based Complement Alternat Med. 2014;2014:365742. [PMC gratuitous commodity] [PubMed] [Google Scholar]
89. Roth T. Insomnia: Definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007;3:S7–x. [PMC free article] [PubMed] [Google Scholar]
90. Lamberg L. Several slumber disorders reflect gender differences. Psychiatry News. 2007;42:40. [Google Scholar]
91. Shi Y, Dong JW, Zhao JH, Tang LN, Zhang JJ. Herbal indisposition medications that target GABAergic systems: A review of the psychopharmacological evidence. Curr Neuropharmacol. 2014;12:289–302. [PMC free article] [PubMed] [Google Scholar]
92. Petramfar P, Zarshenas MM, Moein One thousand, Mohagheghzadeh A. Management of insomnia in traditional Persian medicine. Forsch Komplementmed. 2014;21:119–25. [PubMed] [Google Scholar]
93. Kohnen R, Oswald WD. The effects of valerian, propranolol, and their combination on activation, performance, and mood of good for you volunteers under social stress atmospheric condition. Pharmacopsychiatry. 1988;21:447–8. [PubMed] [Google Scholar]
94. Aptitude Due south, Padula A, Moore D, Patterson K, Mehling W. Valerian for sleep: A systematic review and meta-analysis. Am J Med. 2006;119:1005–12. [PMC gratuitous commodity] [PubMed] [Google Scholar]
95. Akhondzadeh S, Naghavi Hr, Vazirian 1000, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26:363–7. [PubMed] [Google Scholar]
96. Ngan A, Conduit R. A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality. Phytother Res. 2011;25:1153–ix. [PubMed] [Google Scholar]
97. Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized feet disorder. J Clin Psychopharmacol. 2009;29:378–82. [PMC free article] [PubMed] [Google Scholar]
98. Zick SM, Wright BD, Sen A, Arnedt JT. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: A randomized placebo-controlled pilot study. BMC Complement Altern Med. 2011;11:78. [PMC gratuitous article] [PubMed] [Google Scholar]
99. Morin CM, Koetter U, Bastien C, Ware JC, Wooten V. Valerian-hops combination and diphenhydramine for treating indisposition: A randomized placebo-controlled clinical trial. Sleep. 2005;28:1465–71. [PubMed] [Google Scholar]
100. Koetter U, Schrader E, Käufeler R, Brattström A. A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a stock-still valerian hops extract combination (Ze 91019) in patients suffering from non-organic slumber disorder. Phytother Res. 2007;21:847–51. [PubMed] [Google Scholar]
101. Hartley DE, Elsabagh S, File SE. Gincosan (a combination of Ginkgo biloba and Panax ginseng): The effects on mood and cognition of half-dozen and 12 weeks' treatment in post-menopausal women. Nutr Neurosci. 2004;seven:325–33. [PubMed] [Google Scholar]
102. Bradwejn J, Zhou Y, Koszycki D, Shlik J. A double-bullheaded, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. J Clin Psychopharmacol. 2000;twenty:680–4. [PubMed] [Google Scholar]
103. Bystritsky A, Kerwin L, Feusner JD. A pilot written report of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD) J Altern Complement Med. 2008;xiv:175–fourscore. [PubMed] [Google Scholar]
104. Rahimi R, Nikfar Due south, Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: A meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:118–27. [PubMed] [Google Scholar]
105. Lehrl S. Clinical efficacy of kava excerpt WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial. J Affect Disord. 2004;78:101–ten. [PubMed] [Google Scholar]
106. Witte S, Loew D, Gaus W. Meta-assay of the efficacy of the acetonic kava-kava extract WS1490 in patients with not-psychotic feet disorders. Phytother Res. 2005;19:183–eight. [PubMed] [Google Scholar]
107. Lin Y, Wang XY, Ye R, Hu WH, Sun SC, Jiao HJ, et al. Efficacy and safety of Wuling capsule, a single herbal formula, in Chinese subjects with indisposition: A multicenter, randomized, double-blind, placebo-controlled trial. J Ethnopharmacol. 2013;145:320–vii. [PubMed] [Google Scholar]
108. Baek JH, Nierenberg AA, Kinrys M. Clinical applications of herbal medicines for feet and insomnia; targeting patients with bipolar disorder. Aust N Z J Psychiatry. 2014;48:705–15. [PubMed] [Google Scholar]
109. Sarris J. Chinese herbal medicine for sleep disorders: Poor methodology restricts any clear decision. Sleep Med Rev. 2012;16:493–5. [PubMed] [Google Scholar]
110. Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for low, anxiety and indisposition: A review of psychopharmacology and clinical bear witness. Eur Neuropsychopharmacol. 2011;21:841–60. [PubMed] [Google Scholar]
111. Shen B, Truong J, Helliwell R, Govindaraghavan Southward, Sucher NJ. An in vitro report of neuroprotective properties of traditional Chinese herbal medicines thought to promote good for you ageing and longevity. BMC Complement Altern Med. 2013;13:373. [PMC free article] [PubMed] [Google Scholar]
112. Karran Eastward, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer's disease: An appraisement for the development of therapeutics. Nat Rev Drug Discov. 2011;10:698–712. [PubMed] [Google Scholar]
113. Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science. 2002;296:1991–5. [PubMed] [Google Scholar]
114. Krainc D. Clearance of mutant proteins as a therapeutic target in neurodegenerative diseases. Arch Neurol. 2012;67:388–92. [PubMed] [Google Scholar]
115. Rademakers R, Neumann M, Mackenzie IR. Advances in understanding the molecular footing of frontotemporal dementia. Nat Rev Neurol. 2012;viii:423–34. [PMC free article] [PubMed] [Google Scholar]
116. Zhang L, Yu South, Zhang R, Xing Y, Li Y, Li L. Tetrahydroxystilbene glucoside antagonizes age-related a-synuclein overexpression in the hippocampus of APP transgenic mouse model of Alzheimer'due south disease. Restor Neurol Neurosci. 2013;31:41–52. [PubMed] [Google Scholar]
117. Xu SS, Gao ZX, Weng Z, Du ZM, Xu WA, Yang JS, et al. Efficacy of tablet huperzine-A on retention, cognition, and behavior in Alzheimer's illness. Zhongguo Yao Li Xue Bao. 1995;sixteen:391–5. [PubMed] [Google Scholar]
118. Zhang Z, Wang X, Chen Q, Shu L, Wang J, Shan G. Clinical efficacy and safety of huperzine Blastoff in handling of balmy to moderate Alzheimer illness, a placebo-controlled, double-blind, randomized trial. Zhonghua Yi Xue Za Zhi. 2002;82:941–4. [PubMed] [Google Scholar]
119. Chen Fifty, Huang J, Xue L. Upshot of chemical compound Polygonum multiflorum excerpt on Alzheimer'southward disease. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010;35:612–5. [PubMed] [Google Scholar]
120. Li CS, Li J, Guan XH, Wang RX, Wang Xx, Yang ZN, et al. Clinical study of Shouwuyizhi capsule in the treatment of vascular dementia. Chin J Geriatr. 2008;28:369–71. [Google Scholar]
121. Chiu MJ. Efficacy and condom study of DCB-AD1 in patients with mild to moderate Alzheimer'south illness. National Taiwan University Hospital Identifier: NCT00154635. 2005 [Google Scholar]
122. Calapai G. Herbal medicines: The European future scene. Evid Based Complement Alternat Med. 2007;four:69–70. [Google Scholar]
123. Newall CA, Anderson LA, Phillipson JD. A Guide for Health-Care Professionals. 1st ed. 1996. Herbal Medicines; pp. 2–12. [Google Scholar]
124. Barnes J. Pharmacovigilance of herbal medicines: A UK perspective. Drug Saf. 2003;26:829–51. [PubMed] [Google Scholar]
125. Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: A tabular compilation of reported cases. Liver Int. 2012;32:1543–56. [PubMed] [Google Scholar]
126. Teschke R, Genthner A, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: Analysis of cases with initially reported positive re-exposure tests. Dig Liver Dis. 2014;46:264–nine. [PubMed] [Google Scholar]
127. Laird AR, Ramchandani N, deGoma EM, Avula B, Khan IA, Gesundheit N. Acute hepatitis associated with the use of an herbal supplement (Polygonum multiflorum) mimicking iron-overload syndrome. J Clin Gastroenterol. 2008;42:861–2. [PubMed] [Google Scholar]
128. Wang GQ, Deng YQ, Hou FQ. Overview of drug-induced liver injury in China. Clin Liver Dis. 2014;4:26–9. [Google Scholar]
129. Banarova A, Koller T, Payer J. Toxic hepatitis induced past Polygonum multiflorum. Vnitr Lek. 2012;58:958–62. [PubMed] [Google Scholar]
130. Wu X, Chen 10, Huang Q, Fang D, Li Thou, Zhang K. Toxicity of raw and candy roots of Polygonum multiflorum. Fitoterapia. 2012;83:469–75. [PubMed] [Google Scholar]
131. Obodozie OO. Pharmacokinetics and drug interactions of herbal medicines: A missing critical footstep in the phytomedicine/drug development procedure. In: Noreddin A, editor. Reading in Advanced Pharmacokinetics - Theory, Methods, and Applications. Croatia: InTech; 2012. pp. 127–56. [Google Scholar]
132. Williamson Eastward, Driver S, Baxter K. Stockley'southward Herbal Medicines Interactions. London: Pharmaceutical Press; 2009. pp. 1–x. [Google Scholar]
133. Pearson NJ, Johnson LL, Nahin RL. Indisposition, problem sleeping, and complementary and alternative medicine: Analysis of the 2002 national wellness interview survey data. Curvation Intern Med. 2006;166:1775–82. [PubMed] [Google Scholar]
Articles from Pharmacognosy Research are provided here courtesy of Wolters Kluwer -- Medknow Publications
mcavoygonchediess.blogspot.com
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471648/
0 Response to "He Shou Wu Herb Use for Hair Growth Reviews"
Post a Comment